Don’t let the cost of brand combination diabetes therapy disrupt your treatment. We help eligible patients access Jentadueto and Jentadueto XR (linagliptin/metformin) for as little as $69.95 per month through the manufacturer’s Patient Assistance Program.
The Jentadueto Prescription Assistance Program is a manufacturer-sponsored initiative that provides Jentadueto and Jentadueto XR at little or no medication cost to qualifying patients based on income and insurance status. The program is designed for adults with type 2 diabetes who are uninsured or underinsured and cannot afford brand combination therapy.
Navigating the program on your own means dealing with eligibility verification, prescriber coordination, documentation requirements, and renewal deadlines — all while managing a chronic condition that requires consistent daily therapy.
AffordMyPrescriptions eliminates that burden. For a flat $69.95 per month, our Patient Advocates handle every step of your enrollment, from initial application through ongoing refill coordination and annual re-certification — so you focus on your health, not paperwork.
| Pharmacy(With Coupon) | PrIce (30-Day)* | You Save W/ Us |
|---|---|---|
| Walgreens | ~$498.00 | Save ~$428/mo |
| CVS Pharmacy | ~$510.00 | Save ~$440/mo |
| Walmart | ~$485.00 | Save ~$415/mo |
| Costco | ~$478.00 | Save ~$408/mo |
| Kroger | ~$355.00 | Save ~$285/mo |
*Retail prices are estimates based on public data and vary by pharmacy. Coupon prices from GoodRx and SingleCare as of April 2026. Afford My Prescriptions Advocacy Service bypasses retail pricing by using drug manufacturer programs to secure your medication for you—independent of dosage or retail price.
1 Medications
2 Medications
3 Medications
4+ Medications
The Patient Assistance Program is free to apply for and provides Jentadueto at little or no medication cost if approved. But the process involves detailed applications, prescriber coordination, documentation, and ongoing renewal management. Our $69.95/month service covers full advocacy: applications, doctor coordination, documentation, refill management, and annual re-enrollment — so you focus on your health, not paperwork.
Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.
Our specialists help gather documentation, complete applications, and coordinate with program providers.
Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Jentadueto:
Copay accumulators may prevent savings from counting toward your deductible
Fixed $69.95/month — never changes regardless of retail price
Medication supplied directly through the assistance program
If denied, we explore alternative savings paths on your behalf
Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for Jentadueto assistance.
Jentadueto (linagliptin/metformin) is an oral combination tablet for adults with type 2 diabetes. The immediate-release form combines 2.5 mg of linagliptin with 500 mg, 850 mg, or 1,000 mg of metformin, taken twice daily with meals. Jentadueto XR is a once-daily extended-release version taken in the evening with a meal. Maximum daily dose is 5 mg linagliptin and 2,000 mg metformin.
How It Works:
Jentadueto uses two mechanisms to manage type 2 diabetes by combining metformin and linagliptin. Metformin reduces the amount of sugar the liver releases and helps the body use its own insulin more effectively. Linagliptin assists by slowing the breakdown of hormones that signal the pancreas to release more insulin and produce less glucagon when blood sugar levels are high.
Form and Use:
The immediate-release version is taken twice daily with meals, often starting with a lower metformin strength to help the stomach adjust. An extended-release version (Jentadueto XR) is also available, which is taken once daily in the evening with a meal. The maximum total daily dose for this medication is 5 mg of linagliptin and 2,000 mg of metformin.
Generic Availability:
As of 2026, there is no FDA-approved generic for the combined Jentadueto tablet in the U.S. However, both of its active ingredients are available as separate generic medications, with generic metformin being particularly affordable. Patients may discuss with their prescriber whether taking the two components as separate generic tablets is a suitable way to reduce costs.
Warnings:
This medication is not for type 1 diabetes or ketoacidosis and should not be used by patients with severe kidney impairment. It carries a boxed warning for lactic acidosis, a rare but serious condition associated with metformin. Additionally, patients should watch for persistent abdominal pain, which could indicate pancreatitis, a known risk associated with the linagliptin component.
The average retail price is approximately $480 per month for immediate-release Jentadueto and approximately $344 per month for Jentadueto XR with publicly listed GoodRx coupons. Without coupons, prices reach $630 or higher. Through AffordMyPrescriptions, qualifying patients receive Jentadueto at no medication cost — our $69.95 monthly fee covers full advocacy and program management.
Jentadueto is the immediate-release version taken twice daily with meals. Jentadueto XR is an extended-release once-daily tablet taken in the evening with a meal. The two versions deliver the same medicines (linagliptin plus metformin) but have different dosing schedules — and pricing and availability differ between the two.
Yes. Generic linagliptin and generic metformin are both widely available as separate medicines, and generic metformin in particular is among the cheapest prescription medications on the market — often less than $10/month. If you do not specifically need both medicines combined into one tablet, your prescriber may be able to write the components separately as generics — typically dramatically cheaper than brand Jentadueto. We mention this directly because for many patients, splitting the combination into generics is a better path than paying for our advocacy on the brand.
Jentadueto is contraindicated in patients with severe kidney impairment (eGFR below 30 mL/min/1.73 m²) and is not recommended in patients with eGFR between 30 and 45 mL/min/1.73 m². It is not used in type 1 diabetes or diabetic ketoacidosis. Like all metformin-containing products, it carries a boxed warning for lactic acidosis.
If your initial application is denied, we explore alternative savings paths on your behalf — including the manufacturer’s reported cash-pay platform that may offer Jentadueto at significantly reduced prices, the manufacturer’s copay savings card if you have commercial insurance, independent foundations such as the PAN Foundation or HealthWell Foundation, or asking your prescriber whether splitting the combination into generics would meet your treatment goals at much lower cost. If we cannot find a path to medication access, you will not be charged our service fee.
Most enrolled patients receive their first Jentadueto shipment within two to four weeks of completing the documentation. Timing depends on how quickly your prescriber returns the required forms and the program processes your application
If you are struggling with the high cost of Jentadueto, our team may be able to help you access assistance programs designed to make brand combination diabetes therapy affordable. Check your eligibility today and take the first step toward predictable, sustainable treatment.
Start free by filling out a simple online form.
Our specialist will contact you for a quick welcome call.
Our team handles everything, so you can focus on your health.